Literature DB >> 28296032

Right ventricular remodelling after transcatheter pulmonary valve implantation.

Efstathios D Pagourelias1, Ana M Daraban1, Razvan O Mada1, Jürgen Duchenne1, Oana Mirea1, Bjorn Cools2, Ruth Heying2, Derize Boshoff2, Jan Bogaert3, Werner Budts1, Marc Gewillig2, Jens-Uwe Voigt1.   

Abstract

OBJECTIVES: To define the optimal timing for percutaneous pulmonary valve implantation (PPVI) in patients with severe pulmonary regurgitation (PR) after Fallot's Tetralogy (ToF) correction.
BACKGROUND: PPVI among the aforementioned patients is mainly driven by symptoms or by severe right ventricular (RV) dilatation/dysfunction. The optimal timing for PPVI is still disputed.
METHODS: Twenty patients [age 13.9 ± 9.2 years, (range 4.3-44.9), male 70%] with severe PR (≥3 grade) secondary to previous correction of ToF, underwent Melody valve (Medtronic, Minneapolis, MN) implantation, after a pre-stent placement. Full echocardiographic assessment (traditional and deformation analysis) and cardiovascular magnetic resonance evaluation were performed before and at 3 months after the intervention. 'Favorable remodelling' was considered the upper quartile of RV size decrease (>20% in 3 months).
RESULTS: After PPVI, indexed RV effective stroke volume increased from 38.4 ± 9.5 to 51.4 ± 10.7 mL/m2 , (P = 0.005), while RV end-diastolic volume and strain indices decreased (123.1 ± 24.1-101.5 ± 18.3 mL/m2 , P = 0.005 and -23.5 ± 2.5 to -21 ± 2.5%, P = 0.002, respectively). After inserting pre-PPVI clinical, RV volumetric and deformation parameters in a multiple regression model, only time after last surgical correction causing PR remained as significant regressor of RV remodelling [R2  = 0.60, beta = 0.387, 95%CI(0.07-0.7), P = 0.019]. Volume reduction and functional improvement were more pronounced in patients treated with PPVI earlier than 7 years after last RV outflow tract (RVOT) correction, reaching close-to-normal values.
CONCLUSIONS: Early PPVI (<7 years after last RVOT operation) is associated with a more favorable RV reverse remodelling toward normal range and should be considered, before symptoms or RV damage become apparent.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  congenital heart disease adults; imaging TEE/TTE; imaging cardiac magnetic resonance imaging; right ventricular function; transcatheter valve implantation

Mesh:

Year:  2017        PMID: 28296032     DOI: 10.1002/ccd.26966

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

Review 1.  Percutaneous Pulmonary Valve Implantation: Current Status and Future Perspectives.

Authors:  Bart W Driesen; Evangeline G Warmerdam; Gert-Jan Sieswerda; Folkert J Meijboom; Mirella M C Molenschot; Pieter A Doevendans; Gregor J Krings; Arie P J van Dijk; Michiel Voskuil
Journal:  Curr Cardiol Rev       Date:  2019

2.  Percutaneous pulmonary valve implantation in patients with right ventricular outflow tract dysfunction: a systematic review and meta-analysis.

Authors:  Liyu Ran; Wuwan Wang; Francesco Secchi; Yajie Xiang; Wenhai Shi; Wei Huang
Journal:  Ther Adv Chronic Dis       Date:  2019-06-14       Impact factor: 5.091

Review 3.  Percutaneous Pulmonary Valve Implantation.

Authors:  Luca Giugno; Alessia Faccini; Mario Carminati
Journal:  Korean Circ J       Date:  2020-04       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.